Hologic FQ4 top line up 6%; earnings down 21%

Hologic (NASDAQ:HOLX) fiscal Q4 results:

Revenue: $865.8M (+6.4%); Breast Health: $342.6M (+6.3%).

Net income: $39.9M (-21.0%); non-GAAP net income: $175.0M (+10.3%); EPS: $0.15 (-16.7%); non-GAAP EPS: $0.65 (+12.1%).

Cash flow ops (FY): $649.5M (-11.4%).

Fiscal Q1 guidance: Revenue: $835M – 850M; EPS: $0.33 – 0.35; non-GAAP EPS: $0.59 – 0.61.

Fiscal 2020 guidance: Revenue: $3,450M – 3,500M; EPS: $1.59 – 1.64; non-GAAP EPS: $2.60 – 2.65.

Shares up 2% after hours.

Previously: Hologic EPS in-line, beats on revenue (Nov. 6)

https://seekingalpha.com/news/3515794-hologic-fq4-top-line-6-percent-earnings-21-percent